The lecture video:0
Abstract:0
11
3
Date (UTC+8) | Time (UTC+8) | Local Time | Room | Session | Role | Talk Title |
---|---|---|---|---|---|---|
2020-12-16 | 15:35-15:40 | 2020-12-16,15:35-15:40 | Room 1 |
Opening Remarks |
Speaker | 16th ITC Welcome Video |
2020-12-16 | 15:40-16:00 | 2020-12-16,15:40-16:00 | Room 1 |
Opening Remarks |
Speaker | Opening Ceremony Video |
2020-12-16 | 16:00-16:30 | 2020-12-16,16:00-16:30 | Room 1 |
Recent Advances in Thyroidology |
Speaker | Clinical Thyroidology |
2020-12-16 | 16:30-17:00 | 2020-12-16,16:30-17:00 | Room 1 |
Recent Advances in Thyroidology |
Speaker | Basic Thyroidology |
2020-12-16 | 17:00-17:30 | 2020-12-16,17:00-17:30 | Room 1 |
Recent Advances in Thyroidology |
Speaker | Thyroid Autoimmunity |
2020-12-16 | 17:30-18:00 | 2020-12-16,17:30-18:00 | Room 1 |
Recent Advances in Thyroidology |
Speaker | Thyroid Cancer |
2020-12-16 | 18:20-18:45 | 2020-12-16,18:20-18:45 | Room 2 |
Symposium 2 Management of Subclinical Thyroid Dysfunction |
Speaker | AOTA |
2020-12-16 | 18:20-18:45 | 2020-12-16,18:20-18:45 | Room 1 |
Symposium 1 Pediatric Thyroid Nodules and Cancer |
Speaker | Review of Prognostic Factors |
2020-12-16 | 18:45-19:10 | 2020-12-16,18:45-19:10 | Room 1 |
Symposium 1 Pediatric Thyroid Nodules and Cancer |
Speaker | Diagnosis of Pediatric Thyroid Cancer |
2020-12-16 | 18:45-19:10 | 2020-12-16,18:45-19:10 | Room 2 |
Symposium 2 Management of Subclinical Thyroid Dysfunction |
Speaker | ATA |
2020-12-16 | 19:10-19:35 | 2020-12-16,19:10-19:35 | Room 1 |
Symposium 1 Pediatric Thyroid Nodules and Cancer |
Speaker | Management of Persistent Disease |
2020-12-16 | 19:10-19:35 | 2020-12-16,19:10-19:35 | Room 2 |
Symposium 2 Management of Subclinical Thyroid Dysfunction |
Speaker | ETA / EUGOGO |
2020-12-16 | 19:35-20:00 | 2020-12-16,19:35-20:00 | Room 1 |
Symposium 1 Pediatric Thyroid Nodules and Cancer |
Speaker | Surgical Issues |
2020-12-16 | 19:35-20:00 | 2020-12-16,19:35-20:00 | Room 2 |
Symposium 2 Management of Subclinical Thyroid Dysfunction |
Speaker | LATS |
2020-12-17 | 08:00-08:40 | 2020-12-17,08:00-08:40 | Room 1 |
Plenary 1 |
Speaker | Iodine and Thyroid Disorders and Metabolism: Lessons from Universal Salt Iodization in China for 20-years |
2020-12-17 | 08:45-09:10 | 2020-12-17,08:45-09:10 | Room 1 |
Symposium 3 Thyroid Hormone Action in Development |
Speaker | Neural Development |
2020-12-17 | 08:45-09:10 | 2020-12-17,08:45-09:10 | Room 2 |
Symposium 4 Multidisciplinary DTC Care in the Era of Personalization |
Speaker | Active Surveillance |
2020-12-17 | 09:10-09:35 | 2020-12-17,09:10-09:35 | Room 1 |
Symposium 3 Thyroid Hormone Action in Development |
Speaker | Retinal Development |
2020-12-17 | 09:10-09:35 | 2020-12-17,09:10-09:35 | Room 2 |
Symposium 4 Multidisciplinary DTC Care in the Era of Personalization |
Speaker | Extent of Surgery |
2020-12-17 | 09:35-10:00 | 2020-12-17,09:35-10:00 | Room 2 |
Symposium 4 Multidisciplinary DTC Care in the Era of Personalization |
Speaker | Non Surgical Options |
2020-12-17 | 09:35-10:00 | 2020-12-17,09:35-10:00 | Room 1 |
Symposium 3 Thyroid Hormone Action in Development |
Speaker | Skeletal Development |
2020-12-17 | 10:30-11:10 | 2020-12-17,10:30-11:10 | Room 1 |
Plenary 2 |
Speaker | Selective Use of Tyrosine Multi-kinase Inhibitor Therapy in Patients with RR-DTC |
2020-12-17 | 11:15-11:40 | 2020-12-17,11:15-11:40 | Room 2 |
Symposium 6 Reproductive Outcomes of Subclinical Hypothyroidism |
Speaker | Fertility Impact |
2020-12-17 | 11:15-11:40 | 2020-12-17,11:15-11:40 | Room 1 |
Symposium 5 Surgical Management of Graves' Disease |
Speaker | Classical Thyroidectomy |
2020-12-17 | 11:40-12:05 | 2020-12-17,11:40-12:05 | Room 2 |
Symposium 6 Reproductive Outcomes of Subclinical Hypothyroidism |
Speaker | Pregnancy Impact |
2020-12-17 | 11:40-12:05 | 2020-12-17,11:40-12:05 | Room 1 |
Symposium 5 Surgical Management of Graves' Disease |
Speaker | Remote Access Novel Surgical Approaches for Thyroid Surgery |
2020-12-17 | 12:05-12:30 | 2020-12-17,12:05-12:30 | Room 2 |
Symposium 6 Reproductive Outcomes of Subclinical Hypothyroidism |
Speaker | Offspring Impact |
2020-12-17 | 12:05-12:30 | 2020-12-17,12:05-12:30 | Room 1 |
Symposium 5 Surgical Management of Graves' Disease |
Speaker | Orbital Decompression, Eye Muscle and Lid Surgery |
2020-12-17 | 13:30-14:00 | 2020-12-17,13:30-14:00 | Room 1 |
Lilly Satellite Symposium-Dulaglutide Scientific Story: Short Overview |
Chair | |
2020-12-17 | 13:30-14:00 | 2020-12-17,13:30-14:00 | Room 1 |
Lilly Satellite Symposium-Dulaglutide Scientific Story: Short Overview |
Speaker | Dulaglutide Scientific Story: Short Overview |
2020-12-17 | 14:00-14:40 | 2020-12-17,14:00-14:40 | Room 1 |
Plenary 3 |
Speaker | Nuclear Receptor Coregulators: Modulators of Thyroid Hormone Action in Health and Disease |
2020-12-17 | 14:45-15:10 | 2020-12-17,14:45-15:10 | Room 1 |
Symposium 7 Thyroid Hormone Inflammation and Fibrosis |
Speaker | Lung Fibrosis |
2020-12-17 | 14:45-15:10 | 2020-12-17,14:45-15:10 | Room 2 |
Symposium 8 Anaplastic and Poorly Differentiated Thyroid Cancers |
Speaker | Basic Advancement |
2020-12-17 | 15:10-15:35 | 2020-12-17,15:10-15:35 | Room 2 |
Symposium 8 Anaplastic and Poorly Differentiated Thyroid Cancers |
Speaker | Epidemiology and Pathogenesis |
2020-12-17 | 15:10-15:35 | 2020-12-17,15:10-15:35 | Room 1 |
Symposium 7 Thyroid Hormone Inflammation and Fibrosis |
Speaker | Liver Fibrosis |
2020-12-17 | 15:35-16:00 | 2020-12-17,15:35-16:00 | Room 1 |
Symposium 7 Thyroid Hormone Inflammation and Fibrosis |
Speaker | Inflammation |
2020-12-17 | 15:35-16:00 | 2020-12-17,15:35-16:00 | Room 2 |
Symposium 8 Anaplastic and Poorly Differentiated Thyroid Cancers |
Speaker | Review of Animal Models |
2020-12-17 | 16:00-16:25 | 2020-12-17,16:00-16:25 | Room 2 |
Symposium 8 Anaplastic and Poorly Differentiated Thyroid Cancers |
Speaker | Treatment Protocols Including Immunotherapy |
2020-12-17 | 16:00-16:25 | 2020-12-17,16:00-16:25 | Room 1 |
Symposium 7 Thyroid Hormone Inflammation and Fibrosis |
Speaker | Innate Immunity |
2020-12-17 | 16:30-17:30 | 2020-12-17,16:30-17:30 | Room 1 |
Award Lecture-AOTA |
Speaker | AOTA Award Lecture: My Transpacific Journey from the Thyroid to the Liver |
2020-12-18 | 08:00-08:40 | 2020-12-18,08:00-08:40 | Room 1 |
Plenary 4 |
Speaker | Update in the Treatment of Medullary Thyroid Cancer |
2020-12-18 | 08:45-09:10 | 2020-12-18,08:45-09:10 | Room 2 |
Symposium 10 Active Surveillance: The Real World Perspective |
Speaker | Implications and Practicality AOTA |
2020-12-18 | 08:45-09:10 | 2020-12-18,08:45-09:10 | Room 1 |
Symposium 9 Thyroid Hormone Action in Metabolism |
Speaker | The Role of Thyroid Hormone in Brown Adipose Tissue Recruitment |
2020-12-18 | 09:10-09:35 | 2020-12-18,09:10-09:35 | Room 2 |
Symposium 10 Active Surveillance: The Real World Perspective |
Speaker | Implications and Practicality ETA |
2020-12-18 | 09:10-09:35 | 2020-12-18,09:10-09:35 | Room 1 |
Symposium 9 Thyroid Hormone Action in Metabolism |
Speaker | Role of Thyroid Hormone in Hepatic Metabolism |
2020-12-18 | 09:35-10:00 | 2020-12-18,09:35-10:00 | Room 1 |
Symposium 9 Thyroid Hormone Action in Metabolism |
Speaker | Regulation of Insulin Action |
2020-12-18 | 09:35-10:00 | 2020-12-18,09:35-10:00 | Room 2 |
Symposium 10 Active Surveillance: The Real World Perspective |
Speaker | Implications and Practicality LATS |
2020-12-18 | 10:30-11:10 | 2020-12-18,10:30-11:10 | Room 1 |
Plenary 5 |
Speaker | Dissecting the Genetic Architecture of Thyroid Autoimmunity: Implications for Targeted Immune Therapies |
2020-12-18 | 11:15-11:40 | 2020-12-18,11:15-11:40 | Room 1 |
Symposium 11 Management of Graves' Orbitopathy |
Speaker | EUGOGO Guideline |
2020-12-18 | 11:15-11:40 | 2020-12-18,11:15-11:40 | Room 2 |
Symposium 12 Environmental Factors and Thyroid |
Speaker | Selenium in Thyroid |
2020-12-18 | 11:40-12:05 | 2020-12-18,11:40-12:05 | Room 1 |
Symposium 11 Management of Graves' Orbitopathy |
Speaker | Japanese Guidance |
2020-12-18 | 11:40-12:05 | 2020-12-18,11:40-12:05 | Room 2 |
Symposium 12 Environmental Factors and Thyroid |
Speaker | Iron in Pregnancy |
2020-12-18 | 12:05-12:30 | 2020-12-18,12:05-12:30 | Room 2 |
Symposium 12 Environmental Factors and Thyroid |
Speaker | Smoking and the Thyroid |
2020-12-18 | 12:05-12:30 | 2020-12-18,12:05-12:30 | Room 1 |
Symposium 11 Management of Graves' Orbitopathy |
Speaker | Novel Immunosuppression Approaches |
2020-12-18 | 14:00-14:40 | 2020-12-18,14:00-14:40 | Room 1 |
Plenary 6 |
Speaker | Thyroid Disruption: Past, Present and Future |
2020-12-18 | 14:45-15:10 | 2020-12-18,14:45-15:10 | Room 1 |
Symposium 13 Target Tissue Injury and Repair |
Speaker | Kidney Injury |
2020-12-18 | 14:45-15:10 | 2020-12-18,14:45-15:10 | Room 2 |
Symposium 14 Ultrasound Classification of Thyroid Nodules |
Speaker | ACR |
2020-12-18 | 15:10-15:35 | 2020-12-18,15:10-15:35 | Room 2 |
Symposium 14 Ultrasound Classification of Thyroid Nodules |
Speaker | ATA |
2020-12-18 | 15:10-15:35 | 2020-12-18,15:10-15:35 | Room 1 |
Symposium 13 Target Tissue Injury and Repair |
Speaker | Sarcopenia and Myopathies |
2020-12-18 | 15:35-16:00 | 2020-12-18,15:35-16:00 | Room 2 |
Symposium 14 Ultrasound Classification of Thyroid Nodules |
Speaker | K-TIRADS |
2020-12-18 | 15:35-16:00 | 2020-12-18,15:35-16:00 | Room 1 |
Symposium 13 Target Tissue Injury and Repair |
Speaker | Fracture Repair |
2020-12-18 | 16:00-16:25 | 2020-12-18,16:00-16:25 | Room 2 |
Symposium 14 Ultrasound Classification of Thyroid Nodules |
Speaker | EU-TIRADS |
2020-12-18 | 16:00-16:25 | 2020-12-18,16:00-16:25 | Room 1 |
Symposium 13 Target Tissue Injury and Repair |
Speaker | Myelin Repair |
2020-12-18 | 16:30-17:30 | 2020-12-18,16:30-17:30 | Room 1 |
Award Lecture - ATA |
Speaker | ATA Award Lecture: Congenital Hypothroidism - Culprit Genes and Signature Phenotypes |
2020-12-19 | 08:00-08:40 | 2020-12-19,08:00-08:40 | Room 1 |
Plenary 7 |
Speaker | Personalization of DTC Initial Management: From Active Surveillance to Extensive Surgery - Why? |
2020-12-19 | 08:45-09:10 | 2020-12-19,08:45-09:10 | Room 1 |
Symposium 15 Thyroid Hormone and Stem Cell Regulation |
Speaker | Skeletal Muscle Stem Cells |
2020-12-19 | 08:45-09:10 | 2020-12-19,08:45-09:10 | Room 2 |
Symposium 16 Diagnostic Molecular Markers 2020 |
Speaker | Mutations |
2020-12-19 | 09:10-09:35 | 2020-12-19,09:10-09:35 | Room 1 |
Symposium 15 Thyroid Hormone and Stem Cell Regulation |
Speaker | Neural Stem Cells |
2020-12-19 | 09:10-09:35 | 2020-12-19,09:10-09:35 | Room 2 |
Symposium 16 Diagnostic Molecular Markers 2020 |
Speaker | Gene Expression |
2020-12-19 | 09:35-10:00 | 2020-12-19,09:35-10:00 | Room 1 |
Symposium 15 Thyroid Hormone and Stem Cell Regulation |
Speaker | Intestine Stem Cells |
2020-12-19 | 09:35-10:00 | 2020-12-19,09:35-10:00 | Room 2 |
Symposium 16 Diagnostic Molecular Markers 2020 |
Speaker | Liquid Biopsy |
2020-12-19 | 10:30-11:10 | 2020-12-19,10:30-11:10 | Room 1 |
Plenary 8 |
Speaker | Personalization of DTC Initial Management: From Active Surveillance to Extensive Surgery - When? |
2020-12-19 | 11:15-11:40 | 2020-12-19,11:15-11:40 | Room 2 |
Symposium 18 Novel Image Guided Ablative Therapies for Thyroid Nodules and Cancer |
Speaker | RFA |
2020-12-19 | 11:15-11:40 | 2020-12-19,11:15-11:40 | Room 1 |
Symposium 17 Free T4 in Pregnancy |
Speaker | Maternal Hyperthyroxinemia |
2020-12-19 | 11:40-12:05 | 2020-12-19,11:40-12:05 | Room 2 |
Symposium 18 Novel Image Guided Ablative Therapies for Thyroid Nodules and Cancer |
Speaker | Microwave |
2020-12-19 | 11:40-12:05 | 2020-12-19,11:40-12:05 | Room 1 |
Symposium 17 Free T4 in Pregnancy |
Speaker | Maternal Hypothyroxinemia |
2020-12-19 | 14:00-14:40 | 2020-12-19,14:00-14:40 | Room 1 |
Plenary 9 |
Speaker | Mammalian Development: A New and Critical Role for Thyroid Hormone Receptors |
2020-12-19 | 14:45-15:10 | 2020-12-19,14:45-15:10 | Room 2 |
Symposium 20 Thyrotoxicosis in Pregnancy |
Speaker | ATD and Pregnancy |
2020-12-19 | 14:45-15:10 | 2020-12-19,14:45-15:10 | Room 1 |
Symposium 19 LT4 vs. T3 + T4 |
Speaker | Rationale |
2020-12-19 | 15:10-15:35 | 2020-12-19,15:10-15:35 | Room 1 |
Symposium 19 LT4 vs. T3 + T4 |
Speaker | Genetics and Polymorphism |
2020-12-19 | 15:10-15:35 | 2020-12-19,15:10-15:35 | Room 2 |
Symposium 20 Thyrotoxicosis in Pregnancy |
Speaker | ATD and Pregnancy |
2020-12-19 | 15:35-16:00 | 2020-12-19,15:35-16:00 | Room 1 |
Symposium 19 LT4 vs. T3 + T4 |
Speaker | Management in LATS |
2020-12-19 | 15:35-16:00 | 2020-12-19,15:35-16:00 | Room 2 |
Symposium 20 Thyrotoxicosis in Pregnancy |
Speaker | How to Optimally Treat the Mother |
2020-12-19 | 16:00-16:25 | 2020-12-19,16:00-16:25 | Room 1 |
Symposium 19 LT4 vs. T3 + T4 |
Speaker | Management in Japan |
2020-12-19 | 16:00-16:25 | 2020-12-19,16:00-16:25 | Room 2 |
Symposium 20 Thyrotoxicosis in Pregnancy |
Speaker | Prediction and Therapy of Fetal Graves |
2020-12-19 | 16:30-17:30 | 2020-12-19,16:30-17:30 | Room 1 |
Award Lecture-ETA |
Speaker | ETA Award Lecture: Neonatal Thyroxine Activation Modifies Epigenetic Programing of the Liver |
2020-12-20 | 08:00-08:40 | 2020-12-20,08:00-08:40 | Room 1 |
Plenary 10 |
Speaker | The Role of TSH beyond Thyroid |
2020-12-20 | 08:45-09:10 | 2020-12-20,08:45-09:10 | Room 1 |
Symposium 21 Thyroid Hormone and Cancer |
Speaker | Cutaneous Malignancy |
2020-12-20 | 08:45-09:10 | 2020-12-20,08:45-09:10 | Room 2 |
Symposium 22 Thyroid Dysfunction & Diabetes |
Speaker | Type 2 Diabetes and Thyroid Dysfunction |
2020-12-20 | 09:10-09:35 | 2020-12-20,09:10-09:35 | Room 2 |
Symposium 22 Thyroid Dysfunction & Diabetes |
Speaker | Metformin & Thyroid Dysfunction |
2020-12-20 | 09:10-09:35 | 2020-12-20,09:10-09:35 | Room 1 |
Symposium 21 Thyroid Hormone and Cancer |
Speaker | Thyroid Hormones in Cancer Cechechia |
2020-12-20 | 09:35-10:25 | 2020-12-20,09:35-10:25 | Room 1 |
Symposium 21 Thyroid Hormone and Cancer |
Speaker | Bowel malignancy (Declined) |
2020-12-20 | 09:35-10:00 | 2020-12-20,09:35-10:00 | Room 2 |
Symposium 22 Thyroid Dysfunction & Diabetes |
Speaker | Type 1 Diabetes and AITD (Declined) |
2020-12-20 | 10:30-11:10 | 2020-12-20,10:30-11:10 | Room 1 |
Plenary 11 |
Speaker | Molecular Markers as Prognostic Tools to Define Initial Treatment: The Time has Come? |
2020-12-20 | 11:15-11:40 | 2020-12-20,11:15-11:40 | Room 1 |
Symposium 23 Animal Models for AITD |
Speaker | Chinese Model |
2020-12-20 | 11:15-11:40 | 2020-12-20,11:15-11:40 | Room 2 |
Symposium 24 New Concepts and Ideas in the Management of MTC |
Speaker | Calcitonin Based Management and Long Term Outcome |
2020-12-20 | 11:40-12:05 | 2020-12-20,11:40-12:05 | Room 2 |
Symposium 24 New Concepts and Ideas in the Management of MTC |
Speaker | Reconsideration of Locoregional Therapy Options in the Era of RET Kinase Inhibitors |
2020-12-20 | 11:40-12:05 | 2020-12-20,11:40-12:05 | Room 1 |
Symposium 23 Animal Models for AITD |
Speaker | European Model |
2020-12-20 | 14:00-14:40 | 2020-12-20,14:00-14:40 | Room 1 |
Plenary 12 |
Speaker | Genetics of Thyroid Autoimmunity |
2020-12-20 | 14:45-15:10 | 2020-12-20,14:45-15:10 | Room 1 |
Symposium 25 Iodine |
Speaker | Challenges Encountered in Iodinization |
2020-12-20 | 14:45-15:10 | 2020-12-20,14:45-15:10 | Room 2 |
Symposium 26 Thyroid Pathology |
Speaker | Review of Bethesda vs. European or Other Classifications |
2020-12-20 | 15:10-15:35 | 2020-12-20,15:10-15:35 | Room 1 |
Symposium 25 Iodine |
Speaker | Iodine and Selenium Nutritional Status in Latin-America |
2020-12-20 | 15:10-15:35 | 2020-12-20,15:10-15:35 | Room 2 |
Symposium 26 Thyroid Pathology |
Speaker | What should be Stated and Understood from Pathology Report |
2020-12-20 | 16:30-17:30 | 2020-12-20,16:30-17:30 | Room 1 |
Announcement of the 17th ITC-LATS |
Speaker | Announcement of the 17th ITC-LATS |